LAMILUX AntiBac Wins “Best Food Safety Innovation of the Decade” at the Gulfood Manufacturing Awards 2024
One document
more
Stories about Medizin, Gesundheit
Last Call for canSERV Third Open Call Funding
One documentmoreTechnische Universität München
Robotic shorts support people when walking
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE TUM researchers develop shorts with motor power Robotic shorts support people when walking - Same concept as the electric bike, but for walking - Target groups are the elderly as well as people with cardiovascular conditions - Testers used up to 18% less of their own energy to cover a defined distance Researchers at the Technical University of Munich (TUM) have developed ...
moreGrünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
moreLAUDA DR. R. WOBSER GMBH & CO. KG
40th work anniversary at the world market leader
morePulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
Ramat Gan, Israel (ots/PRNewswire) - Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its ...
moreLAUDA DR. R. WOBSER GMBH & CO. KG
LAUDA honors Rainer Deinert for 45 years of company loyalty
moreOttobock invests in NeuroTech company ONWARD® Medical
moreFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
moreEvent Announcement: VIROFIGHT Hybrid Symposium
One documentmoremedac Gesellschaft für klinische Spezialpräparate mbH
medac: CDMO medac group at CPHI in Milan
CPHI 2024 CDMO medac group reflects on successful meetings with business partners at CPHI in Milan Medac CDMO group, a reliable partner in contract development and manufacturing, is pleased to report a series of productive and insightful meetings with both current and potential business partners during this year’s CPHI Congress in Milan, held from 8–10 ...
One documentmoreEpitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference
Caesarea, Israel (ots/PRNewswire) - Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024. ...
moreBetter Health Requires More Participation by Young People
Berlin/Gütersloh (ots) - At this year’s World Health Summit in Berlin, the WHO Youth Council presented its vision for healthier societies. The World Health Organization’s Youth Council is calling on policymakers to better leverage the potential of young people. The Bertelsmann Stiftung and major youth organizations support the initiative. Better involvement of and support for young people is essential to creating a ...
morePress Release: EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar
EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar - STADA announces EMA acceptance of Marketing Authorization Applications for AVT03, a proposed denosumab biosimilar to Prolia® (Bone Health) and Xgeva® (Oncology) - STADA holds marketing rights for AVT03 in Europe, as well ...
moreExtreme Rainfall Poses Health Risks
Extreme Rainfall Poses Health Risks An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to 2020. The key finding: Extremely heavy rainfall, which occurs approximately every five years, significantly increases the risk of death, ...
moreRockefeller Foundation Joins G20 Global Alliance Against Hunger and Poverty to Advance Climate-Resilient School Meals
Rome (ots/PRNewswire) - The Rockefeller Foundation became the first philanthropy to join the Global Alliance Against Hunger and Poverty (Global Alliance) at an event today with its President Rajiv Shah, the Brazilian Ambassador to the Rome-based Agencies, Carla Barroso Carneiro, and The Food and Agriculture ...
moreNorgine Announces Appointment of New CEO Janneke van der Kamp
London (ots/PRNewswire) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, Chris Bath, has stepped down from his role effective immediately. This change in leadership will support and enhance the Company's mission of bringing transformative medicines ...
moreSuccessful MDR Certification for AI Solution in Predicting Postoperative Complications – New Product Generation for Optimized Patient Safety
Berlin (ots) - x-cardiac, a leader in AI-based medical devices for the prediction of postoperative complications after cardiac surgery, is pleased to announce the successful MDR (Medical Device Regulation) certification of its new x-cardiac-platform. This certification introduces a completely new generation of ...
moreGerman Federal Chancellor Scholz, WHO Director-General Dr Tedros and Bill Gates at the World Health Summit 2024 / The world's leading global health conference begins on October 13
Berlin (ots) - The financing of WHO, Germany's role in global health, antimicrobial resistance, Mpox, digitalization - topics like these are on the agenda of this year's World Health Summit from October 13-15 in Berlin. Leading international experts and decision-makers from all sectors will discuss strategies for a ...
moreGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
moreMSD in Strategic collaboration with Briya for Innovative RWE data analysis projects
Tel Aviv, Israel (ots/PRNewswire) - MSD, a leading multinational pharmaceutical company successfully completes a first-of-its-kind strategic collaboration with Briya, a medical data retrieval network. This groundbreaking partnership enabled innovative data analysis projects on three critical disease areas MSD plays a part in. Leveraging Briya's advanced data platform, ...
moreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
moreLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
One documentmoreLaunch of canSERV Call for Service Provision, "Training the Next Generation of Cancer Researchers"
One documentmoreEpitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device
Caesarea, Israel (ots/PRNewswire) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise. Epitomee Medical Ltd. (TASE: EPIT), announced that the United States Food and Drug Administration (FDA) has officially ...
more- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore Scantox Group acquires Gentronix, a world leader in genetic toxicology
Ejby, Denmark (ots/PRNewswire) - Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO"). Gentronix, now integrated into Scantox Group, is well recognized for its high-quality genetic toxicology services and strong scientific engagement, with ...
moreINSIGHTEC; Charles River Laboratories International, Inc.
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Wilmington, Mass., Miami and Haifa, Israel (ots/PRNewswire) - Collaboration stands to advance novel therapeutic applications across multiple neurologic conditions Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to transform ...
more- 2
Record financing rounds at the Munich biotech hub
One documentmore Gabriel Millan joins Mars as Chief Financial Officer for Petcare business
Brussels (ots/PRNewswire) - - Mars announces Gabriel Millan as new CFO for Petcare, Millan will join the Mars Petcare Leadership Team and global Finance Leadership Team - Recognized finance leader with over 25 years' experience in Fortune-500/FTSE-100 companies across consumer goods and life sciences, to join Mars from GSK Today, Mars named Gabriel Millan as Chief ...
more
12345678910Next